-
1
-
2
Corrigendum to ‘Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins’ [Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2255–2263]
Veröffentlicht in Nutrition, metabolism, and cardiovascular diseases
VolltextArtikel -
3
-
4
-
5
Corrigendum to Comparative effectiveness of Glargine 300 U/mL vs. Degludec 100 U/mL in patients with type 2 diabetes switching from 1° generation basal insulins > Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2255-2263
Veröffentlicht in Nutrition, metabolism, and cardiovascular diseases
VolltextArtikel -
6
-
7
-
8
-
9
-
10
Corrigendum to “Comparison of non-HDL-cholesterol versus triglycerides-to-HDLcholesterol ratio in relation to cardiometabolic risk factors and preclinical organ damage in overweight/obese children: The CARITALY study” [Nutr Metab Cardiovasc Dis 25 (2015) 489–494]
Veröffentlicht in Nutrition, metabolism, and cardiovascular diseases
VolltextArtikel -
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20